Product Details
WHO Product ID
NDA 203076 USFDA
Status
Prequalified
INN, dosage form and strength
Lamivudine/Nevirapine/Zidovudine Tablet, Dispersible 30mg/50mg/60mg
Basis of listing
Alternative Listing
Basis of alternative listing
USFDA - PEPFAR
Therapeutic area
HIV/AIDS
Type
Finished Pharmaceutical Product
Dosage form
Tablet, Dispersible
Applicant organization
Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel
Mumbai,
Maharashtra
400 013
India